$8B Philly Risperdal Verdict Ripe For Reduction, Experts Say
Jean Eggen, distinguished professor emerita of law at Delaware Law School, weighs in as an expert in this article outlining a recent verdict against Johnson & Johnson subsidiary Janssen Pharmaceuticals